A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Lorlatinib Impurity 11 | CAS 2857872-22-9 - Request Quote

Picture of Lorlatinib Impurity 11

Lorlatinib Impurity 11

SZ CAT No:SZ-L054016
CAS No
2857872-22-9
Mol.F.
C22H21FN6O4S
Mol.Wt.
484.5
Inv. Status
Synthesis on demand

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Lorlatinib Impurity 11 is chemically . Lorlatinib Impurity 11 is supplied with detailed characterization data compliant with regulatory guideline. Lorlatinib Impurity 11 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lorlatinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 2857872-22-9

Purchase 2857872-22-9

Order 2857872-22-9

Enquire 2857872-22-9

price of 2857872-22-9

2857872-22-9 Supplier

2857872-22-9 Manufacturer

2857872-22-9 Exporter

buy high quality Lorlatinib Impurity 11

Purchase Lorlatinib Impurity 11

Lorlatinib Impurity 11 suppliers

Lorlatinib Impurity 11 manufacturers

Lorlatinib Impurity 11 price

Order Lorlatinib Impurity 11

Enquire Lorlatinib Impurity 11

Lorlatinib Impurity 11 cost

Lorlatinib Impurity 11 Supplier

Lorlatinib Impurity 11 Distributor

Lorlatinib Impurity 11 for Method Validation

Lorlatinib Reference Standard

Lorlatinib Impurity 11 for ANDA Filing

Lorlatinib Impurity 11 for Forced Degradation Studies

Lorlatinib Impurity 11 Identification Standards

Lorlatinib Impurity 11 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,